China Universal Asset Management Co., Ltd. Prelude Therapeutics Inc Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$2.74 - $4.79 $1,065 - $1,863	389 Added 56.62%	1,076 $3,000
Q3 2023 Oct 30, 2023	BUY	$2.74 - $4.79 $1,065 - $1,863	389 Added 56.62%	1,076 $3,000
Q2 2023 May 21, 2024	BUY	$4.45 - $8.12 $169 - $308	38 Added 5.86%	687 $3,000
Q2 2023 Jul 27, 2023	BUY	$4.45 - $8.12 $169 - $308	38 Added 5.86%	687 $3,000
Q1 2023 May 21, 2024	BUY	$4.58 - $7.34 $1,277 - $2,047	279 Added 75.41%	649 $3,000
Q1 2023 Apr 27, 2023	BUY	$4.58 - $7.34 $1,277 - $2,047	279 Added 75.41%	649 $4,000
Q4 2022 May 21, 2024	BUY	$4.61 - $8.5 $1,705 - $3,145	370 New	370 $2,000
Q4 2022 Jan 31, 2023	SELL	$4.61 - $8.5 $359 - $663	-78 Reduced 17.41%	370 $2,000
Q3 2022 Oct 21, 2022	BUY	$5.0 - $8.82 $2,240 - $3,951	448 New	448 $3,000

Others Institutions Holding PRLD

# of Institutions

Shares Held

35.7M

Call Options Held

500

Put Options Held

300

Orbimed Advisors LLC San Diego, CA

10.9M
Shares

$10.5 Million
0.53% of portfolio
Baker Bros. Advisors LP New York, NY

10.1M
Shares

$9.72 Million
0.22% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

3.77M
Shares

$3.62 Million
0.14% of portfolio
Boxer Capital, LLC San Diego, CA

1.71M
Shares

$1.64 Million
0.19% of portfolio
Price T Rowe Associates Inc Baltimore, MD

1.1M
Shares

$1.05 Million
0.0% of portfolio

View Full List

About Prelude Therapeutics Inc

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $34.9M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

More about PRLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account